OpenVSafe by OpenVAERS
Search V-safe

DQM-81193-20118

3 vaccinations 10 coded responses 23 check-ins 10 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
208 / MD
Registered
2021-01-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-05
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-22
    Registered in v-safe
  3. 2021-01-22
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-01-28
    Dose 2 — Pfizer-BioNTech
  5. 2021-01-28
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-01-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  7. 2021-01-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, Itching · Headache
    Free text: Swollen, tender axillary lymph node on the side the vaccine was given
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Itching
    Free text: Swollen axillary lymph node, not as tender today but similar size
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Breast tenderness, Lymphadenopathy — Feeling: Good
    Free text: Swollen left axillary lymph node and mild occasional tenderness in the left lateral breast area
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Lymph node under left arm still enlarged and slightly tender, but getting smaller
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Mild lymph node swelling but much smaller
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-04
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-02-11
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-25
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-04
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-03-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-04-29
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-07-30
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-12-28
    Dose 3 — Pfizer-BioNTech
  21. 2022-01-28
    Survey response — 12 months, dose 2
    MedDRA: Arthralgia, Chills, Headache, Injection site erythema, Injection site pain, Injection site swelling, Lethargy, Lymphadenopathy, Myalgia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: 24 hours after my Pfizer booster on 12/28 I developed an enlarged axillary lymph node, pain, redness, and swelling around the injection site, headache, chills, lethargy, and muscle and joint pain. Symptoms were worse than after my second vaccine.
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-01-28
    Survey response — day 28, dose 3
    MedDRA: Arthralgia, Chills, Headache, Lymphadenopathy, Myalgia, Vaccination site erythema, Vaccination site pain, Vaccination site swelling — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Within 24 hours I developed a very large axillary lymph node, marked redness, pain and swelling at the vaccine site, full body joint and muscle pain, chills, and a headache. Symptoms were worse than after 2nd dose. Improved within 2-3 days.
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-02-02
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  24. 2022-02-08
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  25. 2022-03-29
    Survey response — 3 months, dose 3
    MedDRA: Migraine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Infrequent migraine headaches
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-06-28
    Survey response — 6 months, dose 3
    MedDRA: Arthralgia, Brain fog, COVID-19, Cough, Exposure to SARS-CoV-2, Fatigue, Headache, Memory impairment, Myalgia, Oropharyngeal pain, Respiratory tract congestion, Upper-airway cough syndrome — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Probable COVID-19 starting 4/8/22 for about 10d- headache, muscle & joint pain, coughing, postnasal drip, sore throat, congestion (spouse PCR+ & symptomatic); late April, I started having extreme fatigue, memory issues, & brain fog -slowly improved
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-06-28
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  28. 2022-06-29
  29. 2022-07-01
  30. 2022-07-01
  31. 2022-12-28
    Survey response — 12 months, dose 3
    MedDRA: Chills, Cough, Headache, Myalgia, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Sinus pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Headache, myalgia, sinus pain, congestion, cough, fever, chills, sore throat
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-01-05Pfizer-BioNTech
22021-01-28Pfizer-BioNTech
32021-12-28Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 2

2021-01-30

Systemic reaction (other): Swollen, tender axillary lymph node on the side the vaccine was given

2021-01-31

Systemic reaction (other): Swollen axillary lymph node, not as tender today but similar size

2021-02-01

Systemic reaction (other): Swollen left axillary lymph node and mild occasional tenderness in the left lateral breast area

2021-02-02

Systemic reaction (other): Lymph node under left arm still enlarged and slightly tender, but getting smaller

2021-02-03

Systemic reaction (other): Mild lymph node swelling but much smaller

Release 11 — 12 months, dose 2

2022-01-28

Symptoms: 24 hours after my Pfizer booster on 12/28 I developed an enlarged axillary lymph node, pain, redness, and swelling around the injection site, headache, chills, lethargy, and muscle and joint pain. Symptoms were worse than after my second vaccine.

Release 11 — day 28, dose 3

2022-01-28

Symptoms: Within 24 hours I developed a very large axillary lymph node, marked redness, pain and swelling at the vaccine site, full body joint and muscle pain, chills, and a headache. Symptoms were worse than after 2nd dose. Improved within 2-3 days.

Release 11 — 3 months, dose 3

2022-03-29

Symptoms: Infrequent migraine headaches

Release 12 — 6 months, dose 3

2022-06-28

Symptoms: Probable COVID-19 starting 4/8/22 for about 10d- headache, muscle & joint pain, coughing, postnasal drip, sore throat, congestion (spouse PCR+ & symptomatic); late April, I started having extreme fatigue, memory issues, & brain fog -slowly improved cut off by CDC

Release 12 — 12 months, dose 3

2022-12-28

Symptoms: Headache, myalgia, sinus pain, congestion, cough, fever, chills, sore throat

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia · · ✓
SDBrain fog · · ✓
SDChills · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDExposure to SARS-CoV-2 · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDInjection site erythema · · ✓
SDInjection site pain · · ✓
SDInjection site swelling · · ✓
SDLethargy · · ✓
SDLymphadenopathy · · ✓
SDMemory impairment · · ✓
SDMigraine · · ✓
SDMyalgia · · ✓
SDOropharyngeal pain · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDSinus pain · · ✓
SDUpper-airway cough syndrome · · ✓
SDVaccination site erythema · · ✓
SDVaccination site pain · · ✓
SDVaccination site swelling · · ✓
SROBreast tenderness ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release